Five new drugs or medical devices against cancer invented in France by 2027: this is the bet of the Paris Saclay Cancer Cluster (PSCC), launched a year ago by Gustave Roussy, Sanofi, Inserm, the Polytechnic Institute and Paris-Saclay University.
This project - which is anchored in Villejuif where Gustave Roussy is based - will receive funding of 80 to 100 million euros from the State: the government made it official on Monday morning after a meeting on the strategy decade of the fight against cancer.
The PSCC is thus the first winner of a call for expressions of interest launched by Emmanuel Macron as part of the “France 2030” plan.
Prime Macron 2022: conditions, amount, date of payment... how does it work?
The ambition was to identify “global poles of excellence bringing together companies, care, research and breakthrough innovation, [with] the ambition of transforming the landscape of French biomedical research”.
With 1.3 million deaths each year in Europe (+25% expected by 2035), cancer is one of the…
This article is for subscribers only.
You have 80% left to discover.
Cultivating your freedom is cultivating your curiosity.
Keep reading your article for €0.99 for the first month
I ENJOY IT